US 10001483
Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers
granted A61KA61K31/4035A61K31/454
Quick answer
US patent 10001483 (Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/4035, A61K31/454, A61K31/704, A61K45/06